APO Research
Talk to an analyst

APO RESEARCH · REPORT

Alectinib Drugs

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Alectinib Drugs Market Outlook and Growth Opportunities 2026

2 January 2026195 pages

Choose your research edition.

Industry ResearchAlectinib Drugs Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Alectinib Drugs Industry Growth and Trends Forecast to 203272 pages · $3,450 USDMarket StructureGlobal Alectinib Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032179 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Alectinib Drugs Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Alectinib Drugs Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Alectinib Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Alectinib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Alectinib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Alectinib Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Alectinib Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Alectinib Drugs market include Roche. among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Alectinib Drugs market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Alectinib Drugs and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Alectinib Drugs sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Alectinib Drugs market size, projected growth trends, production technologies, key applications, and end-use industries.

Alectinib Drugs Segment by Company

Roche

Alectinib Drugs Segment by Type

56 Capsules/Bottle

240 Capsules/Bottle

Alectinib Drugs Segment by Application

Hospital

Drugs Store

Alectinib Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Alectinib Drugs status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Alectinib Drugs market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Alectinib Drugs significant trends, drivers, influence factors in global and regions.

6. To analyze Alectinib Drugs competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Alectinib Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Alectinib Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Alectinib Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Alectinib Drugs market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Alectinib Drugs industry.

Chapter 3: Detailed analysis of Alectinib Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Alectinib Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Alectinib Drugs in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Alectinib Drugs Industry Trends Table 2. Alectinib Drugs Industry Drivers Table 3. Alectinib Drugs Industry Opportunities and Challenges Table 4. Alectinib Drugs Industry Restraints Table 5. Global Alectinib Drugs Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Alectinib Drugs Revenue Share by Company (2021-2026) Table 7. Global Alectinib Drugs Sales Volume by Company (Units) & (2021-2026) Table 8. Global Alectinib Drugs Sales Volume Share by Company (2021-2026) Table 9. Global Alectinib Drugs Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Alectinib Drugs Company Ranking, (2024-2026) & (USD Million) Table 11. Global Alectinib Drugs Key Company Manufacturing Base & Headquarters Table 12. Global Alectinib Drugs Company, Product Type & Application Table 13. Global Alectinib Drugs Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Alectinib Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 56 Capsules/Bottle Table 18. Significant Companies of 240 Capsules/Bottle Table 19. Global Alectinib Drugs Sales Volume by Type 2021 VS 2025 VS 2032 (Units) Table 20. Global Alectinib Drugs Sales Volume by Type (2021-2026) & (Units) Table 21. Global Alectinib Drugs Sales Volume by Type (2027-2032) & (Units) Table 22. Global Alectinib Drugs Sales Volume Share by Type (2021-2026) Table 23. Global Alectinib Drugs Sales Volume Share by Type (2027-2032) Table 24. Global Alectinib Drugs Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Alectinib Drugs Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Alectinib Drugs Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Alectinib Drugs Sales Value Share by Type (2021-2026) Table 28. Global Alectinib Drugs Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Drugs Store Table 31. Global Alectinib Drugs Sales Volume by Application 2021 VS 2025 VS 2032 (Units) Table 32. Global Alectinib Drugs Sales Volume by Application (2021-2026) & (Units) Table 33. Global Alectinib Drugs Sales Volume by Application (2027-2032) & (Units) Table 34. Global Alectinib Drugs Sales Volume Share by Application (2021-2026) Table 35. Global Alectinib Drugs Sales Volume Share by Application (2027-2032) Table 36. Global Alectinib Drugs Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Alectinib Drugs Sales Value by Application (2021-2026) & (US$ Million) Table 38. Global Alectinib Drugs Sales Value by Application (2027-2032) & (US$ Million) Table 39. Global Alectinib Drugs Sales Value Share by Application (2021-2026) Table 40. Global Alectinib Drugs Sales Value Share by Application (2027-2032) Table 41. Global Alectinib Drugs Sales by Region: 2021 VS 2025 VS 2032 (Units) Table 42. Global Alectinib Drugs Sales by Region (2021-2026) & (Units) Table 43. Global Alectinib Drugs Sales Market Share by Region (2021-2026) Table 44. Global Alectinib Drugs Sales by Region (2027-2032) & (Units) Table 45. Global Alectinib Drugs Sales Market Share by Region (2027-2032) Table 46. Global Alectinib Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Alectinib Drugs Sales Value by Region (2021-2026) & (US$ Million) Table 48. Global Alectinib Drugs Sales Value Share by Region (2021-2026) Table 49. Global Alectinib Drugs Sales Value by Region (2027-2032) & (US$ Million) Table 50. Global Alectinib Drugs Sales Value Share by Region (2027-2032) Table 51. Global Alectinib Drugs Market Average Price (US$/Unit) by Region (2021-2026) Table 52. Global Alectinib Drugs Market Average Price (US$/Unit) by Region (2027-2032) Table 53. Global Alectinib Drugs Sales by Country: 2021 VS 2025 VS 2032 (Units) Table 54. Global Alectinib Drugs Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 55. Global Alectinib Drugs Sales by Country (2021-2026) & (Units) Table 56. Global Alectinib Drugs Sales Market Share by Country (2021-2026) Table 57. Global Alectinib Drugs Sales by Country (2027-2032) & (Units) Table 58. Global Alectinib Drugs Sales Market Share by Country (2027-2032) Table 59. Global Alectinib Drugs Sales Value by Country (2021-2026) & (US$ Million) Table 60. Global Alectinib Drugs Sales Value Market Share by Country (2021-2026) Table 61. Global Alectinib Drugs Sales Value by Country (2027-2032) & (US$ Million) Table 62. Global Alectinib Drugs Sales Value Market Share by Country (2027-2032) Table 63. Roche Company Information Table 64. Roche Business Overview Table 65. Roche Alectinib Drugs Sales (Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Roche Alectinib Drugs Product Portfolio Table 67. Roche Recent Development Table 68. Key Raw Materials Table 69. Raw Materials Key Suppliers Table 70. Alectinib Drugs Distributors List Table 71. Alectinib Drugs Customers List Table 72. Research Programs/Design for This Report Table 73. Authors List of This Report Table 74. Secondary Sources Table 75. Primary Sources List of Figures Figure 1. Alectinib Drugs Product Image Figure 2. Global Alectinib Drugs Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Alectinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 4. Global Alectinib Drugs Sales (2021-2032) & (Units) Figure 5. Global Alectinib Drugs Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Alectinib Drugs Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 56 Capsules/Bottle Image Figure 10. 240 Capsules/Bottle Image Figure 11. Global Alectinib Drugs Sales Volume by Type (2021 VS 2025 VS 2032) & (Units) Figure 12. Global Alectinib Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Alectinib Drugs Sales Volume Share by Type (2021-2032) Figure 14. Global Alectinib Drugs Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Alectinib Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Alectinib Drugs Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Drugs Store Image Figure 19. Global Alectinib Drugs Sales Volume by Application (2021 VS 2025 VS 2032) & (Units) Figure 20. Global Alectinib Drugs Sales Volume Share 2021 VS 2025 VS 2032 Figure 21. Global Alectinib Drugs Sales Volume Share by Application (2021-2032) Figure 22. Global Alectinib Drugs Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Alectinib Drugs Sales Value Share 2021 VS 2025 VS 2032 Figure 24. Global Alectinib Drugs Sales Value Share by Application (2021-2032) Figure 25. Global Alectinib Drugs Sales by Region: 2021 VS 2025 VS 2032 (Units) Figure 26. Global Alectinib Drugs Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 27. Global Alectinib Drugs Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 28. Global Alectinib Drugs Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 29. North America Alectinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 30. North America Alectinib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 31. Europe Alectinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 32. Europe Alectinib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Asia-Pacific Alectinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 34. Asia-Pacific Alectinib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 35. South America Alectinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 36. South America Alectinib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 37. Middle East & Africa Alectinib Drugs Sales Value (2021-2032) & (US$ Million) Figure 38. Middle East & Africa Alectinib Drugs Sales Value Share by Country (%), 2025 VS 2032 Figure 39. USA Alectinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 40. USA Alectinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 41. USA Alectinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 42. Canada Alectinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. Canada Alectinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. Canada Alectinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Mexico Alectinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Mexico Alectinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Mexico Alectinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Germany Alectinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Germany Alectinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Germany Alectinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. France Alectinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. France Alectinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. France Alectinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. U.K. Alectinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. U.K. Alectinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. U.K. Alectinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. Italy Alectinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. Italy Alectinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. Italy Alectinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Spain Alectinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Spain Alectinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Spain Alectinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Russia Alectinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Russia Alectinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Russia Alectinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Netherlands Alectinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Netherlands Alectinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Netherlands Alectinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Nordic Countries Alectinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Nordic Countries Alectinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Nordic Countries Alectinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. China Alectinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. China Alectinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. China Alectinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. Japan Alectinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. Japan Alectinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. Japan Alectinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. South Korea Alectinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. South Korea Alectinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. South Korea Alectinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. India Alectinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. India Alectinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. India Alectinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. Australia Alectinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. Australia Alectinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. Australia Alectinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Southeast Asia Alectinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Southeast Asia Alectinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Southeast Asia Alectinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Brazil Alectinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Brazil Alectinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Brazil Alectinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Argentina Alectinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Argentina Alectinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Argentina Alectinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Chile Alectinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Chile Alectinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Chile Alectinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Colombia Alectinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Colombia Alectinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Colombia Alectinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Peru Alectinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Peru Alectinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Peru Alectinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Saudi Arabia Alectinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Saudi Arabia Alectinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Alectinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Israel Alectinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Israel Arabia Alectinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Israel Arabia Alectinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. UAE Alectinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. UAE Alectinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. UAE Alectinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. Turkey Alectinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. Turkey Alectinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. Turkey Alectinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Iran Alectinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Iran Alectinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Iran Alectinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Egypt Alectinib Drugs Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Egypt Alectinib Drugs Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Egypt Alectinib Drugs Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Alectinib Drugs Value Chain Figure 124. Manufacturing Cost Structure Figure 125. Alectinib Drugs Sales Mode & Process Figure 126. Direct Comparison with Distribution Share Figure 127. Distributors Profiles Figure 128. Years Considered Figure 129. Research Process Figure 130. Key Executives Interviewed

Scope & coverage.

Types
  • 56 Capsules/Bottle
  • 240 Capsules/Bottle
Applications
  • Hospital
  • Drugs Store
Companies covered
  • Roche

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Alectinib Drugs Sales Value (2021-2032)
  4. 1.2.2 Global Alectinib Drugs Sales Volume (2021-2032)
  5. 1.2.3 Global Alectinib Drugs Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Alectinib Drugs Market Dynamics
  1. 2.1 Alectinib Drugs Industry Trends
  2. 2.2 Alectinib Drugs Industry Drivers
  3. 2.3 Alectinib Drugs Industry Opportunities and Challenges
  4. 2.4 Alectinib Drugs Industry Restraints
3 Alectinib Drugs Market by Company
  1. 3.1 Global Alectinib Drugs Company Revenue Ranking in 2025
  2. 3.2 Global Alectinib Drugs Revenue by Company (2021-2026)
  3. 3.3 Global Alectinib Drugs Sales Volume by Company (2021-2026)
  4. 3.4 Global Alectinib Drugs Average Price by Company (2021-2026)
  5. 3.5 Global Alectinib Drugs Company Ranking (2024-2026)
  6. 3.6 Global Alectinib Drugs Company Manufacturing Base and Headquarters
  7. 3.7 Global Alectinib Drugs Company Product Type and Application
  8. 3.8 Global Alectinib Drugs Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Alectinib Drugs Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Alectinib Drugs Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Alectinib Drugs Market by Type
  1. 4.1 Alectinib Drugs Type Introduction
  2. 4.1.1 56 Capsules/Bottle
  3. 4.1.2 240 Capsules/Bottle
  4. 4.2 Global Alectinib Drugs Sales Volume by Type
  5. 4.2.1 Global Alectinib Drugs Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Alectinib Drugs Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Alectinib Drugs Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Alectinib Drugs Sales Value by Type
  9. 4.3.1 Global Alectinib Drugs Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Alectinib Drugs Sales Value by Type (2021-2032)
  11. 4.3.3 Global Alectinib Drugs Sales Value Share by Type (2021-2032)
5 Alectinib Drugs Market by Application
  1. 5.1 Alectinib Drugs Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Drugs Store
  4. 5.2 Global Alectinib Drugs Sales Volume by Application
  5. 5.2.1 Global Alectinib Drugs Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Alectinib Drugs Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Alectinib Drugs Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Alectinib Drugs Sales Value by Application
  9. 5.3.1 Global Alectinib Drugs Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Alectinib Drugs Sales Value by Application (2021-2032)
  11. 5.3.3 Global Alectinib Drugs Sales Value Share by Application (2021-2032)
6 Alectinib Drugs Regional Sales and Value Analysis
  1. 6.1 Global Alectinib Drugs Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Alectinib Drugs Sales by Region (2021-2032)
  3. 6.2.1 Global Alectinib Drugs Sales by Region: 2021-2026
  4. 6.2.2 Global Alectinib Drugs Sales by Region (2027-2032)
  5. 6.3 Global Alectinib Drugs Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Alectinib Drugs Sales Value by Region (2021-2032)
  7. 6.4.1 Global Alectinib Drugs Sales Value by Region: 2021-2026
  8. 6.4.2 Global Alectinib Drugs Sales Value by Region (2027-2032)
  9. 6.5 Global Alectinib Drugs Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Alectinib Drugs Sales Value (2021-2032)
  12. 6.6.2 North America Alectinib Drugs Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Alectinib Drugs Sales Value (2021-2032)
  15. 6.7.2 Europe Alectinib Drugs Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Alectinib Drugs Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Alectinib Drugs Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Alectinib Drugs Sales Value (2021-2032)
  21. 6.9.2 South America Alectinib Drugs Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Alectinib Drugs Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Alectinib Drugs Sales Value Share by Country, 2025 VS 2032
7 Alectinib Drugs Country-level Sales and Value Analysis
  1. 7.1 Global Alectinib Drugs Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Alectinib Drugs Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Alectinib Drugs Sales by Country (2021-2032)
  4. 7.3.1 Global Alectinib Drugs Sales by Country (2021-2026)
  5. 7.3.2 Global Alectinib Drugs Sales by Country (2027-2032)
  6. 7.4 Global Alectinib Drugs Sales Value by Country (2021-2032)
  7. 7.4.1 Global Alectinib Drugs Sales Value by Country (2021-2026)
  8. 7.4.2 Global Alectinib Drugs Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Alectinib Drugs Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Alectinib Drugs Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Alectinib Drugs Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Alectinib Drugs Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Alectinib Drugs Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Alectinib Drugs Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Alectinib Drugs Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Alectinib Drugs Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Alectinib Drugs Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Alectinib Drugs Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Alectinib Drugs Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Alectinib Drugs Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Alectinib Drugs Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Alectinib Drugs Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Alectinib Drugs Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Alectinib Drugs Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Alectinib Drugs Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Alectinib Drugs Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Alectinib Drugs Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Alectinib Drugs Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Alectinib Drugs Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Alectinib Drugs Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Alectinib Drugs Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Alectinib Drugs Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Alectinib Drugs Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Alectinib Drugs Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Alectinib Drugs Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Alectinib Drugs Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Alectinib Drugs Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Alectinib Drugs Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Alectinib Drugs Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Alectinib Drugs Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Alectinib Drugs Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Alectinib Drugs Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Alectinib Drugs Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Alectinib Drugs Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Alectinib Drugs Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Alectinib Drugs Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Alectinib Drugs Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Alectinib Drugs Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Alectinib Drugs Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Alectinib Drugs Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Alectinib Drugs Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Alectinib Drugs Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Alectinib Drugs Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Alectinib Drugs Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Alectinib Drugs Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Alectinib Drugs Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Alectinib Drugs Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Alectinib Drugs Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Alectinib Drugs Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Alectinib Drugs Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Alectinib Drugs Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Alectinib Drugs Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Alectinib Drugs Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Alectinib Drugs Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Alectinib Drugs Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Alectinib Drugs Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Alectinib Drugs Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Alectinib Drugs Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Alectinib Drugs Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Alectinib Drugs Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Alectinib Drugs Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Alectinib Drugs Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Alectinib Drugs Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Alectinib Drugs Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Alectinib Drugs Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Alectinib Drugs Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Alectinib Drugs Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Alectinib Drugs Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Alectinib Drugs Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Alectinib Drugs Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Alectinib Drugs Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Alectinib Drugs Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Alectinib Drugs Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Alectinib Drugs Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Alectinib Drugs Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Alectinib Drugs Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Alectinib Drugs Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Alectinib Drugs Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Alectinib Drugs Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Alectinib Drugs Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Alectinib Drugs Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Alectinib Drugs Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Roche
  2. 8.1.1 Roche Company Information
  3. 8.1.2 Roche Business Overview
  4. 8.1.3 Roche Alectinib Drugs Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Roche Alectinib Drugs Product Portfolio
  6. 8.1.5 Roche Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Alectinib Drugs Value Chain Analysis
  2. 9.1.1 Alectinib Drugs Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Alectinib Drugs Sales Mode & Process
  6. 9.2 Alectinib Drugs Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Alectinib Drugs Distributors
  9. 9.2.3 Alectinib Drugs Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst